Ciprodex and Mesalamine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ciprodex (ciprofloxacin; dexamethasone) and Mesalamine (mesalamine). Common drug interactions include urinary tract infection among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Ciprodex and Mesalamine. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Ciprodex?

Ciprodex has active ingredients of ciprofloxacin; dexamethasone. It is often used in otitis. eHealthMe is studying from 1,887 Ciprodex users. Check the latest studies of Ciprodex.

What is Mesalamine?

Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 28,053 Mesalamine users. Check the latest studies of Mesalamine.



On Aug, 12, 2026

13 people who take Ciprodex and Mesalamine together, and have interactions are studied.

Ciprodex and Mesalamine drug interactions.

What are the common drug interactions of Ciprodex and Mesalamine, by gender? *:

female:

  1. Urinary tract infection
  2. Cardiac failure congestive
  3. Upper respiratory tract infection
  4. Infusion site pain
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Blood magnesium decreased
  7. Blood potassium decreased
  8. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  9. Autism spectrum disorder (developmental disabilities that can cause significant social, communication and behavioural challenges)
  10. Blood pressure decreased

male:

  1. Asthma
  2. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  3. Scratch
  4. Wheezing (a high-pitched whistling sound made while you breath)
  5. Chest discomfort
  6. Cough
  7. Dyspnoea (difficult or laboured respiration)
  8. Forced expiratory volume decreased (decreased lung expired air volume)
  9. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  10. Injection site pain

What are the common drug interactions of Ciprodex and Mesalamine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Asthma
  2. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  3. Chest discomfort
  4. Cough
  5. Dyspnoea (difficult or laboured respiration)
  6. Forced expiratory volume decreased (decreased lung expired air volume)
  7. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  8. Injection site pain
  9. Mean cell volume decreased (less of the average red blood cell volume)
  10. Red blood cell count increased

50-59:

n/a

60+:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Blood magnesium decreased
  3. Nausea (feeling of having an urge to vomit)
  4. Neck pain
  5. Respiratory tract infection
  6. Blood potassium decreased
  7. Cardiac failure congestive
  8. Infusion site pain
  9. Upper respiratory tract infection
  10. Urinary tract infection

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 10 people, 76.92%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 23.08%
  3. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 3 people, 23.08%
  4. Asthma: 3 people, 23.08%
  5. Arrhythmias (irregular heartbeat): 3 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take Ciprodex and Mesalamine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ciprodex and Mesalamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ciprodex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mesalamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ciprodex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mesalamine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ciprofloxacin; dexamethasone and mesalamine (the active ingredients of Ciprodex and Mesalamine, respectively), and Ciprodex and Mesalamine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: